In one niche, the risk to women is too great
By Judy Norsigian,
The Boston Globe
| 11. 14. 2010
[Op-Ed]
Not all stem cell research is in women's best interest.
The issue of embryonic stem cell research has long been clouded by certain activists — notably those from conservative Christian groups — who seek to stop all such research because it involves destruction of an embryo. In contrast, many pro-choice women’s health advocates like my own organization have long supported most embryonic stem cell research. But there is a small subset of this research we oppose — somatic cell nuclear transfer (SCNT, also called embryo cloning or research cloning) — because of substantial concerns about health risks for the women who provide the fresh eggs that this research demands.
As part of SCNT, the nucleus of an egg (from an egg donor) is removed, and the nucleus of an adult stem cell is inserted in its place. By contrast, conventional embryonic stem cell research utilizes otherwise discarded embryos from fertility clinics, and does not require freshly harvested eggs, where women undergo the risks of egg extraction solely for research purposes. This distinction is crucial.
Because thousands of women regularly undergo...
Related Articles
By Staff, ABC News | 06.01.2026
The Victorian government is introducing legislation it says will make IVF clinics safer and more accountable following high-profile bungles by private providers.
As part of the changes, the state's health minister will have the power to personally intervene to cancel...
By Sofia Resnick, Stateline | 05.20.2026
An anti-abortion group last month sued seven Utah fertility clinics, claiming their disposal of embryos as part of the in vitro fertilization process violates the state’s wrongful death law.
The ministry Voice for the Voiceless believes it has a strong...
By Laura Hughes, Financial Times | 05.20.2026
Sophie and her husband are set to spend more than £100,000 in travel and medical bills as they fly between England and the US in their bid to have another child.
The couple are undergoing IVF treatment in New York...
By Rebecca Roberts, The Scientist | 05.19.2026
Scientists have had prenatal gene therapy in their sights for decades; by treating the fetus in utero, they can potentially prevent the long-term damage caused by severe, early-onset genetic disorders. Despite its success in preclinical studies, the method has...